Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Varex Imaging Corp Director's Dealing 2018

Feb 21, 2018

32856_dirs_2018-02-20_52a5d90b-2fc3-4762-9c0d-094e9753205d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Varex Imaging Corp (VREX)
CIK: 0001681622
Period of Report: 2017-02-16

Reporting Person: WILSON DOW R (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-15 Common Stock M 5148 $37.10 Acquired 24948 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-15 Deferred Stock Units $ M 5148 Disposed Common Stock (5148) Direct

Footnotes

F1: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2: These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017

F3: These shares vested on February 15, 2018.